ICUI Financials: ICU Medical Inc AI Analysis



Financials

ICUI Financial

ICU Medical Inc

$126.43

2.73%

$3.36

At close: May 08, 16:00:00 GMT-4

$126.43

Post-market: May 08, 20:00:00 GMT-4

Overview Forecast Earnings Dividends Financials

Key Stats

Prev.Close

$123.07

Open

$125

Day's Range

$123.07 - $130.21

52 week range

$107 - $160.29

Volume

500.0K

Avg.Volume

268.6K

Dividend yield

EPS (TTM)

0.02

Market Cap

$3.1B

What is ICUI?

ICU Medical, Inc. develops, manufactures, and sells innovative medical products used in infusion therapy and critical care applications. The company is headquartered in San Clemente, California and currently employs 15,000 full-time employees. Its product portfolio includes ambulatory, syringe, and large volume IV pumps and safety software; dedicated and non-dedicated IV sets, needlefree IV connectors, peripheral IV catheters, and sterile IV solutions; closed system transfer devices and pharmacy compounding systems; as well as a range of respiratory, anesthesia, patient monitoring, and temperature management products. Its Infusion Therapy products include Clave needlefree products, Neutron, ClearGuard, and Tego. Its oncology products include ChemoLock Closed System Transfer Devices (CSTD) and Deltec GRIPPER non-coring needles for portal access. Its vascular access products include Safe-T Wing venipuncture and blood collection devices; Port-A-Cath implantable port, and Portex arterial blood sampling syringes. Its Tracheostomy products include Portex BLUselect PVC tracheostomy tubes.

Features

Markets

News

Income

Balance sheet

Cash flow

Annual

Quarterly

ICUI Income

Financials in millions USD. Fiscal year is February - January.

Breakdown	TTM	12/31/2025	09/30/2025	06/30/2025	03/31/2025	12/31/2024
Revenue	2,231	540	536	548	604	629
Revenue Growth (YoY)	-6%	-14%	-9%	-8%	7%	7%
Cost of Revenue	1,409	337	336	340	394	402
Gross Profit	822	202	200	208	210	227
Selling, General & Admin	623	155	152	158	157	158
Research & Development	87	21	21	21	23	22
Operating Expenses	712	176	174	181	180	179
Other Non Operating Income (Expenses)	0	0	0	0	0	0
Pretax Income	4	-15	-2	33	-10	8
Income Tax Expense	2	-2	0	1	4	32
Net Income	0	-15	-3	35	-15	-23
Net Income Growth	-100%	-35%	-91%	-267%	-62%	35%
Shares Outstanding (Diluted)	24.68	24.68	24.68	24.7	24.53	24.49
Shares Change (YoY)	1%	1%	1%	1%	1%	1%
EPS (Diluted)	0.02	-0.63	-0.13	1.43	-0.63	-0.97
EPS Growth	-101%	-34%	-90%	-263%	-61%	37%
Free Cash Flow	82	34	24	-10	34	13
Free Cash Flow Per Share	--	--	--	--	--	--
Gross Margin	36.84%	37.4%	37.31%	37.95%	34.76%	36.08%
Operating Margin	4.88%	4.81%	4.85%	4.74%	4.8%	7.47%
Profit Margin	0%	-2.77%	-0.55%	6.38%	-2.48%	-3.65%
Free Cash Flow Margin	3.67%	6.29%	4.47%	-1.82%	5.62%	2.06%
EBITDA	110	26	26	26	29	47
EBITDA Margin	4.93%	4.81%	4.85%	4.74%	4.8%	7.47%
D&A For EBITDA	1	0	0	0	0	0
EBIT	109	26	26	26	29	47
EBIT Margin	4.88%	4.81%	4.85%	4.74%	4.8%	7.47%
Effective Tax Rate	50%	13.33%	0%	3.03%	-40%	400%

Follow-Up Questions

What are ICU Medical Inc's key financial statements?



According to the latest financial statement (Form-10K), ICU Medical Inc has a total asset of $0, Net loss of $0

What are the key financial ratios for ICUI?



ICU Medical Inc's Current ratio is 0, has a Net margin is 0, sales per share of $0.

How is ICU Medical Inc's revenue broken down by segment or geography?



ICU Medical Inc largest revenue segment is Consumables, at a revenue of 1,109,130,000 in the most earnings release.For geography, United States is the primary market for ICU Medical Inc, at a revenue of 1,356,114,000.

Is ICU Medical Inc profitable?



no, according to the latest financial statements, ICU Medical Inc has a net loss of $0

Does ICU Medical Inc have any liabilities?



no, ICU Medical Inc has liability of 0

How many outstanding shares for ICU Medical Inc?



ICU Medical Inc has a total outstanding shares of 0

ICU Medical Inc (ICUI) Financial

ICUI Stock Price Chart